Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer

NCT02140021 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02140021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02140021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
October 27, 2014
Completion date
July 8, 2025
Enrollment
409 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical adenocarcinoma in situ, cervical intraepithelial neoplasia, cervical squamous cell carcinoma, not otherwise specified, cervical squamous intraepithelial neoplasia, early invasive cervical adenocarcinoma, early invasive cervical squamous cell carcinoma, high grade cervical squamous intraepithelial neoplasia, high grade vaginal intraepithelial neoplasia, low grade vaginal intraepithelial neoplasia, stage i cervical cancer ajcc v8, stage i vaginal cancer ajcc v8, stage i vulvar cancer ajcc v8, stage ia cervical cancer ajcc v8, stage ia vaginal cancer ajcc v8, stage ia vulvar cancer ajcc v8, stage ia1 cervical cancer ajcc v8, stage ia2 cervical cancer ajcc v8, stage ib cervical cancer ajcc v8, stage ib vaginal cancer ajcc v8, stage ib vulvar cancer ajcc v8, stage ib1 cervical cancer ajcc v8, stage ib2 cervical cancer ajcc v8, stage ii cervical cancer ajcc v8, stage ii vaginal cancer ajcc v8, stage ii vulvar cancer ajcc v8, stage iia cervical cancer ajcc v8, stage iia vaginal cancer ajcc v8, stage iia1 cervical cancer ajcc v8, stage iia2 cervical cancer ajcc v8, stage iib cervical cancer ajcc v8, stage iib vaginal cancer ajcc v8, stage iii cervical cancer ajcc v8, stage iii vaginal cancer ajcc v8, stage iii vulvar cancer ajcc v8, stage iiia cervical cancer ajcc v8, stage iiia vulvar cancer ajcc v8, stage iiib cervical cancer ajcc v8, stage iiib vulvar cancer ajcc v8, stage iiic vulvar cancer ajcc v8, stage iv cervical cancer ajcc v8, stage iv vaginal cancer ajcc v8, stage iv vulvar cancer ajcc v8, stage iva cervical cancer ajcc v8, stage iva vaginal cancer ajcc v8, stage iva vulvar cancer ajcc v8, stage ivb cervical cancer ajcc v8, stage ivb vaginal cancer ajcc v8, stage ivb vulvar cancer ajcc v8, vaginal adenocarcinoma, vulvar adenocarcinoma, vulvar high grade squamous intraepithelial lesion, vulvar intraepithelial neoplasia, vulvar squamous cell carcinoma, vulvar squamous intraepithelial lesion